Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”

Radiation Oncology

Ludmila Schneider¹  Ulrike Pflugradt¹  Philipp Baumeister¹  Christine Woischke¹  Ute Ganswindt¹  Thomas Kirchner¹  Horst Zitzelsberger¹  Claus Belka¹  Lars Schüttrumpf¹  Julia Hess¹  Cornelius Maihoefer¹  Corinna Macht²  Axel Walch³ 

[1] Clinical Cooperation Group ‘Personalized Radiotherapy in Head and Neck Cancer’, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH;Gemeinschaftspraxis für Strahlentherapie und Radioonkolgie am Klinikum Schwabing;Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH;

关键词: Head and neck cancer;    Squamous cell carcinoma;    Postoperative;    Adjuvant;    Chemoradiation;    Radiation therapy;   

DOI  :  10.1186/s13014-018-1067-1

来源: DOAJ

【 摘 要 】

Abstract Background Postoperative (chemo) radiation improves tumor control and survival in high-risk patients with head and neck squamous cell carcinoma based on established risk factors. The clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer” focuses on the identification and validation of new biomarkers, which are aimed at eventually stratifying and personalizing the therapy concept. Hence, we reviewed all patients with head and neck squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx, treated with postoperative (chemo) radiation from 06/2008 until 06/2015 at the Department of Radiation Oncology in the University Hospital, LMU Munich. Here we report the clinical results of the cohort, laying the foundation for further research within the framework of a clinical cooperation group. Methods Patient data were retrospectively (until 2013) and prospectively (from 2013) collected and analyzed for outcome and treatment failures with regard to previously described and established risk factors. Results We identified 302 patients (median follow-up 45 months, average age 60.7 years), having received postoperative (chemo)radiation (median 64 Gy). Chemotherapy was added in 58% of cases, mostly Cisplatin/5- Fluorouracil in concordance with the ARO 96–3 study. The 3-year overall survival, local, locoregional and distant failure estimates were 70.5, 9.7, 12.2 and 13.5%, respectively. Human papillomavirus-associated oropharyngeal cancer was associated with a significant improved overall survival, locoregional, distant and overall tumor control rates in multivariate analysis. Additionally, in multivariate analysis, for local failure, resection status and perineural invasion, for locoregional and distant failure extracapsular extension and for overall survival the presence of nodal disease were significant adverse factors. Moreover, 138 patients have been treated in concordance with the ARO 96–3 protocol, corroborating the results of this study. Conclusions Our cohort represents a large unselected cohort of patients with head and neck squamous cell carcinoma treated with postoperative (chemo)radiation. Tumor control rates and survival rates are consistent with the results of previously reported data.

【 授权许可】

Unknown